Watch Ticker

Glaukos Corporation

Go to Glaukos Corporation Website

$88.76

0.70 (0.79%)

Live

Previous Close

$88.06

Day Range

$87.371 - $90.005

Previous Day Range

$84.58 - $89.375

Market Cap

$5.0 billion USD

Day Vol.

281700

Previous Day Vol.

1.8 million

Currency

USD

Primary Exchange

New York Stock Exchange

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenc...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks - Glaukos Stocks Rides on Strong Product Demand Amid Competition

Glaukos Corporation is focused on developing and commercializing surgical devices and pharmaceutical therapies for glaucoma treatment. The company's iStent product line and global glaucoma and Corneal Health franchises are performing well, despite competition and supply chain challenges. Glaukos is also advancing its pipeline, including iDose TREX, iDose ROCK, and iLution Travoprost.

Related tickers: GKOS, DGX, BSX.

Read Full Article

N/A - Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings? - Zacks Investment Research

Boston Scientific Corporation is scheduled to report its Q2 2024 results on July 24. The company is expected to report revenue growth of around 11.7% and adjusted earnings of 58 cents per share. However, the company may face challenges from a challenging supply environment, rising costs, and healthcare staffing shortages.

Related tickers: BSX, EYE, GKOS, TNDM.

Read Full Article

Trending Tickers

Please sign in to view